Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
NCT04084730
This study is recruiting at 9 US sites in 4 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to determine if the dose of radiation therapy that is effective in producing a treatment response, delivered over a shorter treatment period, is a safe approach that causes few or mild side effects in women with newly diagnosed breast cancer or DCIS who have had a lumpectomy procedure.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Invasive Ductal Breast Carcinoma
- Invasive Ductal Carcinoma, Breast
- DCIS
- DCIS Grade 1
- DCIS Grade 2
- Breast Cancer
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 45 years and older
- Sex
- Female
- Healthy volunteers
- Not accepted
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Last updated on ClinicalTrials.gov
- September 21, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Connecticut · 1
- Norwalk Hospital · Norwalk, CT
Florida · 1
- Baptist Alliance Miami Cancer Institute · Miami, FL
New Jersey · 3
- Memorial Sloan Kettering Basking Ridge · Basking Ridge, NJ
- Memorial Sloan Kettering Monmouth · Middletown, NJ
- Memorial Sloan Kettering Bergen · Montvale, NJ
New York · 4
- Memorial Sloan Kettering Commack · Commack, NY
- Memorial Sloan Kettering Westchester · Harrison, NY
- Memorial Sloan Kettering Cancer Center · New York, NY
- Memorial Sloan Kettering Nassau · Uniondale, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.